HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Vasoflux

prepared by depolymerization of heparin, restricting molecular size to 3-8 kDa & reducing antithrombin affinity by periodate oxidation; inactivates fibrin-bound thrombin & attenuates factor Xa generation
Networked: 1 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. White, H: 1 article (08/2001)
2. Weitz, J I: 1 article (08/2001)
3. Peters, R J: 1 article (08/2001)
4. Molhoek, P G: 1 article (08/2001)
5. Gibson, M: 1 article (08/2001)
6. Spickler, W: 1 article (08/2001)
7. Anderson, H V: 1 article (08/2001)
8. Hirsh, J: 1 article (08/2001)
9. Weaver, W D: 1 article (08/2001)
10. Théroux, P: 1 article (08/2001)

Related Diseases

1. Hemorrhage
2. Myocardial Infarction

Related Drugs and Biologics

1. Streptokinase
2. Aspirin (Acetylsalicylic Acid)
3. Heparin (Liquaemin)
4. Factor IXa (Coagulation Factor IXa)
5. Heparin Cofactor II
6. Thrombin
7. Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
8. Fibrin
9. Factor X (Stuart Factor)